180
Participants
Start Date
October 1, 2020
Primary Completion Date
January 31, 2026
Study Completion Date
January 31, 2026
Immunofluorescence Imaging
Patients will be administered FDA approved ICG through intravenous injection and imaged by a FDA approved surgical microscope (Spy Elite) which is 0.5 meter away from the subject. Both ICG fluorescence and the two imaging systems have been used for routine clinical practice for many years. Figure (a) shows the Schematic sketch of the imaging systems. ICG fluorescence imaging utilizes intravenously injected ICG, which is a fluorescent dye that is FDA-approved for clinical use, illuminated with near-infrared light. The ICG dye is indirectly activated and the dynamic fluorescence due to bone perfusion can be captured by a video rate imaging system.
University of Maryland, Baltimore R. Cowley Shock Trauma, Baltimore
University of California, Irvine, Irvine
Brigham and Women's Hospital, Boston
Dartmouth Hitchcock Medical Center, Lebanon
Dartmouth College
OTHER
United States Department of Defense
FED
Brigham and Women's Hospital
OTHER
University of California, Irvine
OTHER
University of Maryland, Baltimore
OTHER
Dartmouth-Hitchcock Medical Center
OTHER